You're using an outdated browser. Please upgrade to a modern browser for the best experience.
Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort by:
Most Viewed Latest Alphabetical (A-Z) Alphabetical (Z-A)
Filter:
All Topic Review Biography Peer Reviewed Entry Video Entry
Topic Review
Role of Partial Splenectomy in Hematologic Childhood Disorders
The spleen is a secondary lymphoid organ that belongs to the reticular-endothelial system, directly connected to blood circulation. The spleen is greatly involved in the immune response, especially against capsulated bacteria. Splenectomy plays a fundamental role in the treatment of numerous pediatric hematologic disorders. Taking into account all the possible complications (especially infections) linked to this procedure, partial splenectomy has been proposed as a treatment that allows the reduction of infectious risk. This approach has proven safe and feasible in most patients, but multicentric and prospective studies are necessary to more accurately define the indications for performing partial splenectomy.
  • 968
  • 16 Nov 2021
Topic Review
Resistance and Cross-Resistance of Chlorhexidine
Chlorohexidine (CHX) is a widely used biocide in clinical and household settings. Studies have reported CHX resistance in different bacterial species, but at concentrations well below those used in the clinical setting. Synthesis of these findings is hampered by the inconsistent compliance with standard laboratory procedures for biocide susceptibility testing. Meanwhile, studies of in vitro CHX-adapted bacteria have reported cross-resistance between CHX and other antimicrobials. This could be related to common resistance mechanisms of CHX and other antimicrobials and/or the selective pressure driven by the intensive use of CHX. Importantly, CHX resistance and cross-resistance to antimicrobials should be investigated in clinical as well as environmental isolates to further understanding of the role of CHX in selection of multidrug resistance. Whilst clinical studies to support the hypothesis of CHX cross-resistance with antibiotics are currently lacking, researchers recommend raising the awareness of healthcare providers in a range of clinical disciplines regarding the potential adverse impact of the unfettered use of CHX on tackling antimicrobial resistance.
  • 966
  • 06 May 2023
Topic Review
Molecular Diagnosis of Colorectal Cancer by Biomarkers
Colorectal cancer (CRC) is a serious disease that affects millions of people throughout the world, despite considerable advances in therapy. The formation of colorectal adenomas and invasive adenocarcinomas is the consequence of a succession of genetic and epigenetic changes in the normal colonic epithelium. Genetic and epigenetic processes associated with the onset, development, and metastasis of sporadic CRC have been studied in depth, resulting in identifying biomarkers that might be used to predict behaviour and prognosis beyond staging and influence therapeutic options. A novel biomarker, or a group of biomarkers, must be discovered in order to build an accurate and clinically useful test that may be used as an alternative to conventional methods for the early detection of CRC and to identify prospective new therapeutic intervention targets. To minimise the mortality burden of colorectal cancer, new screening methods with higher accuracy and nano-based diagnostic precision are needed. 
  • 962
  • 25 Jan 2022
Topic Review
Heme Oxygenase-1 and Iron Metabolism Crosstalk in Macrophages
Heme oxygenase-1 (HO-1) is an enzyme that catalyzes the degradation of heme, releasing equimolar amounts of carbon monoxide (CO), biliverdin (BV), and iron. The anti-inflammatory and antioxidant properties of HO-1 activity are conferred in part by the release of CO and BV and are extensively characterized. However, iron constitutes an important product of HO-1 activity involved in the regulation of several cellular biological processes. The macrophage-mediated recycling of heme molecules, in particular those contained in hemoglobin, constitutes the major mechanism through which living organisms acquire iron. This process is finely regulated by the activities of HO-1 and of the iron exporter protein ferroportin. The expression of both proteins can be induced or suppressed in response to pro- and anti-inflammatory stimuli in macrophages from different tissues, which alters the intracellular iron concentrations of these cells. 
  • 961
  • 28 Jun 2022
Topic Review
Genetic and Epigenetic of Pediatric Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia is the most common malignancy in children and is characterized by numerous genetic and epigenetic abnormalities. Epigenetic mechanisms, including DNA methylations and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. 
  • 960
  • 14 Jan 2022
Topic Review
Links between Protein O-GlcNAcylation and Inflammatory Disease
Unresolved hyperglycaemia, a hallmark of type 2 diabetes mellitus (T2DM), is a well characterised manifestation of altered fuel homeostasis and our understanding of its role in the pathologic activation of the inflammatory system continues to grow. Metabolic disorders like T2DM trigger changes in the regulation of key cellular processes such as cell trafficking and proliferation, and manifest as chronic inflammatory disorders with severe long-term consequences. Activation of inflammatory pathways has recently emerged as a critical link between T2DM and inflammation. The hexosamine biosynthetic pathway(HBP), a unique nutrient-sensing metabolic pathway, produces the activated amino sugar UDP-GlcNAc which is a critical substrate for protein O-GlcNAcylation, a dynamic, reversible post-translational glycosylation of serine and threonine residues in target proteins. Protein O-GlcNAcylation impacts a range of cellular processes, including inflammation, metabolism, trafficking, and cytoskeletal organisation.
  • 960
  • 11 Mar 2022
Topic Review
Misdiagnosis of SARS-CoV-2
SARS-CoV-2 has been the biggest pandemic since the influenza outbreak of 1918-1919. One of the biggest differences during the COVID-19 pandemic, in comparison to 1918-1919, has been the ability to rapidly test and diagnose the presence of the virus within patients and the general public. As with every testing regime, there is always going to be false negatives and misdiagnoses. The aim of this critical review was to assess the factors contributing to misdiagnosis of COVID-19 by examining sample types, diagnostic methods and by looking at asymptomatic versus symptomatic patients. It was found that a combination of detection methods such as the additional use of a computer tomography scan may help in reducing the level of false negatives in both symptomatic and asymptomatic patients. It was concluded that sputum and oral throat-washing samples should take precedence over swabbing where possible, while sample pooling should be used for widespread screening within the general population. The novel Oxford antibody assay was found to have the highest sensitivity and specificity of all commercially available kits, but should only be used within a specific timeframe to avoid misdiagnosis. Similarly, sample collection time and test method can greatly affect the outcome of the diagnostic method being conducted.
  • 956
  • 24 Jun 2021
Topic Review
Cognitive Behavioral Therapy for Migraine Headache
Migraine headaches are chronic neurological diseases that reduce the quality of life by causing severe headaches and autonomic nervous system dysfunction, such as facial flushing, nasal stuffiness, and sweating. Their major treatment methods include medication and cognitive behavioral therapy (CBT). CBT has been used for pain treatment and various psychogenic neurological diseases by reducing pain, disability, and emotional disorders caused by symptoms of mental illness and improving the understanding of mental health.
  • 954
  • 20 Jan 2022
Topic Review
Multi-Organ Histopathological Changes
Infection with SARS-CoV-2, the virus responsible for the global COVID-19 pandemic, causes a respiratory illness that can severely impact other organ systems and is possibly precipitated by cytokine storm, septic shock, thrombosis, and oxidative stress. SARS-CoV-2 infected individuals may be asymptomatic or may experience mild, moderate, or severe symptoms with or without pneumonia.
  • 951
  • 13 Sep 2021
Topic Review
Vitamin D in Cardiovascular Diseases
Vitamin D represents a group of secosteroids involved in the calcium and phosphate metabolism. The active form of vitamin D, 1,25-dihydroxylcalciferol, exerts its biological mechanisms via the VDR which acts as a regulator of several target genes.
  • 944
  • 24 Jan 2022
Topic Review
Monoclonal Antibodies and JAK-Inhibitors for Type 2 Inflammation
Bronchial asthma and its frequent comorbidity chronic rhinosinusitis (CRS), are characterized by an inflammatory process at lower and upper respiratory tract, with a variability in terms of clinical presentations (phenotypes) and distinct underpin pathophysiological mechanisms (endotypes). Based on the characteristics of inflammation, bronchial asthma can be distinguished into type 2 (eosinophilic) or nontype 2 (noneosinophilic) endotypes. In type 2 asthma endotype, the pathogenic mechanism is sustained by an inflammatory process driven by Th2 cells, type 2 innate lymphoid cells (ILC2) and type 2 cytokines, which include interleukin (IL)-4, IL-5, IL-9 and IL-13.
  • 942
  • 15 Nov 2021
Topic Review
Intermediate- and Therapeutic-Dose Anticoagulation for Patients with COVID-19
COVID-19 patients are at high thrombotic risk. Moderately affected COVID-19 patients may benefit from therapeutic-dose anticoagulation, but the risk for bleeding is increased.
  • 940
  • 12 Jan 2022
Topic Review
Hepatitis C Vaccination
The hepatitis C virus (HCV) is a common cause of chronic liver disease and liver cancer worldwide. Despite advances in curative therapies for HCV, the incidence of new infections is not decreasing at the expected rate to hit the World Health Organization (WHO) target for the elimination of HCV by 2030. In fact, there are still more new cases of infection in the United States and worldwide than are being cured. The reasons for the rise in new cases include poor access to care and the opioid epidemic. The clinical burden of HCV requires a multimodal approach to eradicating the infection. Vaccination would be an excellent tool to prevent incidence of new infections; however, the genetic diversity of HCV and its ability to generate quasispecies within an infected host make creating a broadly reactive vaccine difficult. Multiple vaccine candidates have been identified, but to date, there has not been a target that has led to a broadly reactive vaccine, though several of the candidates are promising. Additionally, the virus is very difficult to culture and testing candidates in humans or chimpanzees is ethically challenging. Despite the multiple barriers to creating a vaccine, vaccination still represents an important tool in the fight against HCV. 
  • 940
  • 07 Feb 2022
Topic Review
HCC and Molecular Targeting Therapies
Hepatocellular carcinoma (HCC) is one of the leading causes of death from cancer in the world. Recently, the effectiveness of new antiviral therapies and the HBV vaccine have reduced HCC’s incidence, while non-alcoholic steato-hepatitis is an emerging risk factor. This entry focuses on antiangiogenic molecules and immune checkpoint inhibitors approved for HCC treatment and possible future approaches.
  • 938
  • 12 Oct 2021
Topic Review
Vascular Complications of Diabetes Mellitus
Diabetes mellitus is a comprehensive expression to identify a condition of chronic hyperglycemia whose causes derive from different metabolic disorders characterized by altered insulin secretion or faulty insulin effect on its targets or often both mechanisms . Atherosclerosis (ATS) is the most frequent cause of arterial vasculopathy and is undoubtedly an insidious condition: it is unlikely to be the trigger in coronary artery disease, ischemic stroke, and peripheral artery disease (PAD) on its own; instead, it acts together with other chronic degenerative diseases such as arterial hypertension and diabetes mellitus to constitute the physiopathological basis of cardio- and cerebrovascular accidents.
  • 937
  • 03 Mar 2022
Topic Review
Relationship between Saliva and Sublingual Immunotherapy
Sublingual immunotherapy (SLIT) can induce the clinical remission of patients from IgE-mediated allergic diseases, but not all patients who undergo SLIT experience substantial improvement in their allergic symptoms. As biomarkers to predict the efficacy of SLIT have been investigated, some of the salivary microorganisms which turn out to be associated with the efficacy of SLIT are detected, and these microorganisms may be used as adjuvants for SLIT in the future.
  • 936
  • 29 Mar 2022
Topic Review
Monoclonal Antibodies for Chronic Spontaneous Urticaria
H1-antihistamines (H1AH) represent the current mainstay of treatment for chronic spontaneous urticaria (CSU). However, the response to H1AH is often unsatisfactory, even with increased doses. Therefore, guidelines recommend the use of omalizumab as an add-on treatment in refractory CSU. This paved the way for the investigation of targeted therapies, such as monoclonal antibodies (mAbs), in CSU. Omalizumab remains the best choice to treat refractory CSU. 
  • 936
  • 12 Aug 2022
Topic Review
Interventions for Early-Stage Pericoronitis
Evidence of low methodological quality and high clinical diversity showed that there are still uncertainties to estimate the effect of the different interventions for pericoronitis. It is important to note that pericoronitis is an inflammation of the tissues around the crown. Until now, initial pericoronitis should be resolved with local irrigation and gently debridement. Antibiotics should be specially reserved for severe cases when systemic dissemination are present. 
  • 935
  • 21 Feb 2022
Topic Review
Lung Cancer Immunotherapy
Lung cancer is one of the most deadly of solid cancers. Advanced lung cancer is a prevalent disease with high mortality and low response to conventional cytotoxic therapies. Lung cancer is classified into different histological types, such as adenocarcinoma, squamous cell carcinoma, large cell carcinoma (commonly referred to as non-small cell lung cancer (NSCLC)), and small cell lung cancer (SCLC), and the treatment strategy varies depending on the histological type, as well as the degree of progression.
  • 934
  • 21 Oct 2021
Topic Review
Clinical Assessment for Allergen Immunotherapy Candidates
Since there is no gold standard for screening tests, physicians should (or should not) order them based on a tailor-made approach to each AIT candidate, taking under consideration contraindications and the predictive value of each test. Undoubtedly, more research is required in order to establish a universal approach.
  • 933
  • 02 Mar 2022
  • Page
  • of
  • 18
Academic Video Service